< 生产厂家 价格 >

8-羟基喹啉

8-羟基喹啉用途

8-Hydroxyquinoline是单质子二齿螯合剂, 可用作防腐剂, 消毒剂和杀虫剂, 用作转录抑制剂。
点击显示

8-羟基喹啉名称

[ CAS 号 ]:
148-24-3

[ 中文名 ]:
8-羟基喹啉

[ 英文名 ]:
8-Hydroxyquinoline

[中文别名 ]:

[英文别名 ]:

8-羟基喹啉生物活性

8-羟基喹啉物理化学性质

[ 密度 ]:
1.3±0.1 g/cm3

[ 沸点 ]:
267.0±0.0 °C at 760 mmHg

[ 熔点 ]:
70-73 °C(lit.)

[ 分子式 ]:
C9H7NO

[ 分子量 ]:
145.158

[ 闪点 ]:
143.1±20.4 °C

[ 精确质量 ]:
145.052765

[ PSA ]:
33.12000

[ LogP ]:
1.87

[ 外观性状 ]:
白色至淡黄色晶体

[ 蒸汽压 ]:
0.0±0.5 mmHg at 25°C

[ 折射率 ]:
1.691

[ 储存条件 ]:
Store at RT.

[ 水溶解性 ]:
INSOLUBLE

8-羟基喹啉MSDS

8-羟基喹啉毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VC4200000
CHEMICAL NAME :
8-Quinolinol
CAS REGISTRY NUMBER :
148-24-3
BEILSTEIN REFERENCE NO. :
0114512
LAST UPDATED :
199712
DATA ITEMS CITED :
47
MOLECULAR FORMULA :
C9-H7-N-O
MOLECULAR WEIGHT :
145.17
WISWESSER LINE NOTATION :
T66 BNJ JQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1210 mg/m3/6H
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
20 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
43 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
83600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD20 - Lethal Dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1205 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
45 gm/kg/15D-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Musculoskeletal - other changes Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
45 gm/kg/15D-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Musculoskeletal - other changes Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
29 gm/kg/48W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Reproductive - Tumorigenic effects - testicular tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
33 gm/kg/82W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - ovarian tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
7200 mg/kg/50W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Reproductive - Tumorigenic effects - ovarian tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
900 mg/kg/21W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Reproductive - Tumorigenic effects - ovarian tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5600 mg/kg/35W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia Reproductive - Tumorigenic effects - ovarian tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
34 gm/kg/84W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Reproductive - Tumorigenic effects - uterine tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors Tumorigenic - tumors at site of application
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Intravaginal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
17 gm/kg/2Y-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - ovarian tumors
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Micronucleus test

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Rodent - hamster Ovary
DOSE/DURATION :
2600 ug/L
REFERENCE :
SCIEAS Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- Volume(issue)/page/year: 236,933,1987 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 13,101,1977 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 13,101,1977 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW INTEAG Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1960- Volume(issue)/page/year: 15,7,1974 TOXICOLOGY REVIEW AEHLAU Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- Volume(issue)/page/year: 23,6,1971 TOXICOLOGY REVIEW 85CVA2 "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 Volume(issue)/page/year: 5,250,1970 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 81590 No. of Facilities: 685 (estimated) No. of Industries: 8 No. of Occupations: 10 No. of Employees: 5733 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 81590 No. of Facilities: 857 (estimated) No. of Industries: 6 No. of Occupations: 10 No. of Employees: 13728 (estimated) No. of Female Employees: 9645 (estimated)
点击显示

8-羟基喹啉安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H302

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ 危害码 (欧洲) ]:
Xn:Harmful

[ 风险声明 (欧洲) ]:
R22;R36/37/38;R68

[ 安全声明 (欧洲) ]:
S45-S36/37/39-S26

[ 危险品运输编码 ]:
2811

[ WGK德国 ]:
3

[ RTECS号 ]:
VC4200000

[ 海关编码 ]:
2933499090

8-羟基喹啉合成路线

8-羟基喹啉上下游产品

8-羟基喹啉制备

1.由邻氨基苯酚经环合反应制得。将甘油加入耐酸反应锅内,在搅拌下缓缓加入浓硫酸,同时将邻氨基苯酚、邻硝基苯酚依次加入,发烟硫酸先加入总量的65%。加热升温至125℃,停止加热,自然升温至140℃,待温度回降至136℃。将其余的发烟硫酸继续加入,温度保持在137℃。加酸结束后,保温4h,冷却至100℃以下,抽入盛放10倍量水(按邻氨基苯酚计)的耐酸锅中,搅拌,加热至75-80℃,用30%的氢氧化钠溶液中和至pH为7-7.2。趁热放出沉淀物,冷却成块状,经减压升华,得8-羟基喹啉成品。

2.将邻氨基酚、邻硝基酚、甘油、冰乙酸混合,分次加入浓硫酸,将混合物加热至开始沸腾为止。然后在油浴上回流,用水蒸气蒸馏的方法除去未反应的邻硝基苯酚。冷却,用氢氧化钠溶液中和,并以水蒸气蒸馏的方法回收,即得8-羟基喹啉。

3.由喹啉经磺化得到8-磺酸基喹啉,再经过碱熔得到8-羟基喹啉碱,最后经酸化得到8-羟基喹啉。制取工艺如下:

①磺化过程 以喹啉为原料,在搅拌条件下将原料慢慢加入到硫酸中,砂浴加热,在100~180℃下,磺化2~3h。然后自然冷却至室温,再用冰水进一步冷却,过滤烘干,得产物8-磺酸基喹啉。
②碱熔过程 在搅拌条件下,慢慢将磺化品加入到熔融的碱中,在200~240℃左右熔融30~40min,冷却后加入热水,并加热,使其全部溶解,冷却至室温后,再用稀酸中和至pH=7,待结晶析出后,抽滤,将滤饼晾干。
③蒸馏过程 将碱熔产品用水蒸气蒸馏,冷却,结晶即为产品8-羟基喹啉。

点击显示

8-羟基喹啉海关

[ 海关编码 ]: 2933499090

[ 中文概述 ]:
2933499090. 其他含喹琳或异喹啉环系的化合物〔但未进一步稠合的〕. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

[ Summary ]:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

8-羟基喹啉文献

Selective growth-inhibitory effect of 8-hydroxyquinoline towards Clostridium difficile and Bifidobacterium longum subsp. longum in co-culture analysed by flow cytometry.

J. Med. Microbiol. 63(Pt 12) , 1663-9, (2014)

The major risk factor for Clostridium difficile infection (CDI) is the use of antibiotics owing to the disruption of the equilibrium of the host gut microbiota. To preserve the beneficial resident pro...

Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.

Anticancer Res. 34(12) , 7077-90, (2014)

Currently used platinum drugs fail to provide long-term cure for ovarian cancer mainly because of acquired drug resistance. In this study, a new monofunctional planaramineplatinum(II) complex, namely ...

An analytical quality by design (aQbD) approach for a L-asparaginase activity method.

J. Pharm. Biomed. Anal. 117 , 232-9, (2015)

L-asparaginase is an effective anti-tumor agent for acute lymphoblastic leukemia. This work presents the development of an activity determination of L-ASNase preparations for pharmaceutical quality co...


更多文献

相关化工产品/化学物质:

推荐生产厂家/供应商:

公司名:南通润丰石油化工有限公司

区域:南通市崇川区

价格:
¥需询单/1kg ¥需询单/1ton

联系人:曹经理

产品详情:8-羟基喹啉


公司名:上海吉至生化科技有限公司

区域:上海市奉贤区

价格:
¥268.0/500g ¥78.0/100g ¥需询单/1mg ¥468.0/1kg

联系人:刘佳

产品详情:8-羟基喹啉


公司名:上海脉铂医药科技有限公司

区域:上海市嘉定区

价格:
¥549.0/100mg ¥1689.0/500mg ¥需询单/1g ¥需询单/1g

联系人:李先生

产品详情:8-Hydroxyquinoline


公司名:上海创赛科技有限公司

区域:上海市嘉定区

价格:
¥81.0/100g ¥251.0/500g ¥986.0/2500g ¥42.0/25g

联系人:夏言

产品详情:[Perfemiker]8-羟基喹啉,生物技术级


公司名:上海阿拉丁生化科技股份有限公司

区域:上海市浦东新区

价格:
¥70.9/100g ¥39.9/25g ¥212.9/500g ¥376.9/250mg

联系人:阿拉丁李高志

产品详情:8-羟基喹啉


查看所有供应商请点击:

8-羟基喹啉供应商


相关化合物

【8-羟基喹啉】化源网提供8-羟基喹啉CAS号148-24-3,8-羟基喹啉MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询8-羟基喹啉上化源网,专业又轻松。>>电脑版:8-羟基喹啉

标题:8-羟基喹啉_MSDS_用途_密度_8-羟基喹啉CAS号【148-24-3】_化源网 地址:https://m.chemsrc.com/mip/cas/148-24-3_1076110.html